Search Count: 21
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, UMN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, DMS, UMN
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, UNW |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, DMS, UNW
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, UO5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, UO5
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, UOH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, UOH
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.63 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, EDO, UOE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, DMS, EDO, UOE
 |
Discovery Of Astx029, A Clinical Candidate Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2021-10-06 Classification: SIGNALING PROTEIN Ligands: SO4, UOW |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2021-10-06
Ligands: SO4, UOW
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, EQT
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQW |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, EQW
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERZ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, ERZ
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EU2 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, EU2
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQZ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, EQZ
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ESQ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, ESQ
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ER8 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, ER8
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERW |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, ERW
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERK |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, ERK
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ESK |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, ESK
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ESW |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, ESW
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ESN |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, ESN
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, F3Z |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, DMS, F3Z
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, EVK |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: SO4, DMS, EVK